Owens & Minor Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

In the latest quarter, 4 analysts provided ratings for Owens & Minor OMI, showcasing a mix of bullish and bearish perspectives.

The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.

Insights from analysts' 12-month price targets are revealed, presenting an average target of $25.75, a high estimate of $28.00, and a low estimate of $23.00. Surpassing the previous average price target of $23.00, the current average has increased by 11.96%.

Decoding Analyst Ratings: A Detailed Look

The standing of Owens & Minor among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Owens & Minor. This information provides a snapshot of how analysts perceive the current state of the company.
• Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Owens & Minor compared to the broader market.
• Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Owens & Minor's stock. This comparison reveals trends in analysts' expectations over time.

Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Owens & Minor's market standing. Stay informed and make well-considered decisions with our Ratings Table.

Stay up to date on Owens & Minor analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Delving into Owens & Minor's Background

Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.

Owens & Minor's Financial Performance

Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.

Positive Revenue Trend: Examining Owens & Minor's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.12% as of 31 December, 2023, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.

Net Margin: Owens & Minor's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 0.67%, the company showcases strong profitability and effective cost management.

Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 1.96%, the company showcases effective utilization of equity capital.

Return on Assets (ROA): Owens & Minor's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.35% ROA, the company effectively utilizes its assets for optimal returns.

Debt Management: Owens & Minor's debt-to-equity ratio is notably higher than the industry average. With a ratio of 2.51, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.

Understanding the Relevance of Analyst Ratings

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.

Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.

This article was generated by Benzinga's automated content engine and reviewed by an editor.